Safety and Tolerability in Relapsing-Remitting Multiple Sclerosis Patients Treated With High-Dose Subcutaneous Interferon-Beta by Rebiject Autoinjection Over a 1-Year Period-Reference-Cited by-同舟云学术

Safety and Tolerability in Relapsing-Remitting Multiple Sclerosis Patients Treated With High-Dose Subcutaneous Interferon-Beta by Rebiject Autoinjection Over a 1-Year Period

Published:2008-05 Issue:3 Volume:31 Page:167-172
ISSN:0362-5664
Container-title:Clinical Neuropharmacology
language:en
Short-container-title:

Author:

Lugaresi Alessandra,Durastanti Valentina,Gasperini Claudio,Lai Marina,Pozzilli Carlo,Orefice Giuseppe,Sotgiu Stefano,Pucci Emilio,Ardito Bruno,Millefiorini Enrico

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Reference17 articles.

1. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial.;Neurology,1995

2. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).;Jacobs;Ann Neurol,1996

3. 1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.;Lancet,1998

4. Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of relapses and disability by interferon-beta1a subcutaneously in multiple sclerosis.;Li;Ann Neurol,1999

5. PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.;Neurology,2001

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in the market for drug delivery devices categorized as combination drugs and medical devices and regulatory challenges for autoinjectors in Japan;Frontiers in Medical Technology;2024-08-06

2. Autoinjector – A smart device for emergency cum personal therapy;Saudi Pharmaceutical Journal;2021-10

3. Using video‐based training for button‐free auto‐injection of subcutaneous methotrexate: A pilot study;Musculoskeletal Care;2019-08-02

4. Evaluation of performance, acceptance, and compliance of an auto-injector in healthy and rheumatoid arthritic subjects measured by a motion capture system;Patient Preference and Adherence;2018-04

5. Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study;Expert Opinion on Drug Delivery;2017-12-05